The most common ones include cough, sore throat, fever, shortness of breath, sudden onset of anosmia, ageusia or dysgeusia, nausea or vomiting, and diarrhea. The course of COVID-19 is generally mild or moderate in more than 80% of cases, but it is severe or critical in about 14% and...
infections, fatigue, weakness (asthenia), high temperature (pyrexia), nausea, vomiting, diarrhea, oral inflammation (stomatitis), decreased appetite, increase in liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST), taste disorder (dysgeusia), hair loss (alopecia), and oth...
Our observations are supported by a review of studies reporting changes to the mouth or tongue in people with COVID-19, published in December. The researchers found that having adry mouth was the most common problem, followed by loss of taste (dysgeusia) and fungal infection (oral thrush). ...
Gadavist (gadobutrol) is a macrocylic contrast agent manufactured by Bayer. The FDA first approved the drug in 2011 for use in MRIs in adults and children to detect abnormalities and visualize areas within the central nervous system. The drug is also approved to assess breast cancer, evaluate...